Bradley Foster & Sargent’s Quest Diagnostics DGX Stock Holding History

Bradley Foster & Sargent’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$319K	Hold	1,503	–	–	﹤0.01%	472
2026 Q1	$295K	Buy	1,503 +25	+2%	+$4.86K	﹤0.01%	458
2025 Q4	$256K	Hold	1,478	–	–	﹤0.01%	488
2025 Q3	$282K	Sell	1,478 -19	-1%	-$3.37K	﹤0.01%	472
2025 Q2	$269K	Sell	1,497 -51	-3%	-$8.86K	﹤0.01%	478
2025 Q1	$262K	Hold	1,548	–	–	﹤0.01%	419
2024 Q4	$234K	Hold	1,548	–	–	﹤0.01%	438
2024 Q3	$240K	Hold	1,548	–	–	﹤0.01%	436
2024 Q2	$212K	Hold	1,548	–	–	﹤0.01%	436
2024 Q1	$206K	Sell	1,548 -100	-6%	-$13K	﹤0.01%	431
2023 Q4	$227K	Hold	1,648	–	–	﹤0.01%	412
2023 Q3	$232K	Hold	1,648	–	–	﹤0.01%	412
2023 Q2	$232K	Hold	1,648	–	–	﹤0.01%	412
2023 Q1	$233K	Sell	1,648 -2	-0.1%	-$286	0.01%	405
2022 Q4	$258K	Hold	1,650	–	–	0.01%	385
2022 Q3	$202K	Hold	1,650	–	–	0.01%	409
2022 Q2	$219K	Hold	1,650	–	–	0.01%	416
2022 Q1	$226K	Sell	1,650 -100	-6%	-$13.9K	﹤0.01%	440
2021 Q4	$303K	Hold	1,750	–	–	0.01%	389
2021 Q3	$254K	Buy	1,750 +2	+0.1%	+$293	0.01%	375
2021 Q2	$231K	Hold	1,748	–	–	0.01%	379
2021 Q1	$224K	Hold	1,748	–	–	0.01%	358
2020 Q4	$208K	Sell	1,748 -821	-32%	-$100K	0.01%	358
2020 Q3	$294K	Buy	+2,569	New	+$304K	0.01%	305
2020 Q1	$283K	Sell	3,519 -500	-12%	-$51.8K	0.01%	286
2019 Q4	$429K	Buy	4,019 +1,148	+40%	+$120K	0.01%	282
2019 Q3	$307K	Buy	2,871 +229	+9%	+$23.5K	0.01%	296
2019 Q2	$269K	Sell	2,642 -250	-9%	-$24K	0.01%	310
2019 Q1	$260K	Hold	2,892	–	–	0.01%	316
2018 Q4	$241K	Hold	2,892	–	–	0.01%	315
2018 Q3	$312K	Sell	2,892 -565	-16%	-$62K	0.01%	318
2018 Q2	$380K	Buy	3,457 +65	+2%	+$6.77K	0.01%	304
2018 Q1	$340K	Hold	3,392	–	–	0.01%	299
2017 Q4	$334K	Hold	3,392	–	–	0.01%	298
2017 Q3	$318K	Sell	3,392 -481	-12%	-$51.1K	0.01%	302
2017 Q2	$431K	Hold	3,873	–	–	0.02%	273
2017 Q1	$380K	Hold	3,873	–	–	0.02%	282
2016 Q4	$356K	Hold	3,873	–	–	0.02%	283
2016 Q3	$328K	Hold	3,873	–	–	0.01%	288
2016 Q2	$315K	Buy	3,873 +70	+2%	+$5.33K	0.01%	285
2016 Q1	$272K	Hold	3,803	–	–	0.01%	287
2015 Q4	$271K	Hold	3,803	–	–	0.01%	287
2015 Q3	$234K	Hold	3,803	–	–	0.01%	308
2015 Q2	$276K	Hold	3,803	–	–	0.01%	311
2015 Q1	$292K	Sell	3,803 -500	-12%	-$35.8K	0.01%	306
2014 Q4	$289K	Hold	4,303	–	–	0.01%	294
2014 Q3	$261K	Hold	4,303	–	–	0.01%	314
2014 Q2	$253K	Sell	4,303 -1,500	-26%	-$87.8K	0.01%	311
2014 Q1	$336K	Hold	5,803	–	–	0.02%	277
2013 Q4	$311K	Hold	5,803	–	–	0.02%	291
2013 Q3	$359K	Hold	5,803	–	–	0.02%	260
2013 Q2	$352K	Buy	+5,803	New	+$346K	0.02%	255

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Bradley Foster & Sargent's DGX Position: Q2 2026 in Review

Bradley Foster & Sargent held its Quest Diagnostics (DGX) position steady in Q2 2026 at 1,503 shares worth $319K. The position accounts for ﹤0.01% of the portfolio, ranked #472.

Bradley Foster & Sargent first reported a position in DGX in Q2 2013 and has held it in 52 quarters since. The position peaked at $431K in Q2 2017. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

Bradley Foster & Sargent held 1,503 shares of Quest Diagnostics worth $319K as of Q2 2026.
Bradley Foster & Sargent left its Quest Diagnostics share count unchanged in Q2 2026.
Quest Diagnostics made up ﹤0.01% of Bradley Foster & Sargent's portfolio in Q2 2026, its #472 holding.
Bradley Foster & Sargent first reported a position in Quest Diagnostics in Q2 2013 and has held it in 52 quarters since.
Bradley Foster & Sargent's Quest Diagnostics position peaked at $431K in Q2 2017.
1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Bradley Foster & Sargent's 13F filing for Q2 2026, filed 14 Aug 2026.